Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Johnson & Johnson Innovation Announces Launch of Shanghai Lung Cancer Innovation QuickFire Challenge 2018-06-14 15:21
JHL Biotech Announces Completion of Convertible Bond Issuance and Appointment of New Chief Financial Officer 2018-06-14 04:54
CStone Pharmaceuticals Initiates Two Pivotal Phase II Studies of the Anti-PD-L1 Monoclonal Antibody CS1001 2018-06-13 15:09
Dr. Ming Liu joins ChemPartner as Vice President and Head of Biology and Pharmacology 2018-06-12 23:00
Merck Drives Thought Leadership in Ethical Gene Editing 2018-06-12 20:00
China Biologic Receives CFDA Clinical Trial Approval for Human Fibrin Sealant 2018-06-11 20:00
Ketamine Clinics of Los Angeles Makes History as the First Ketamine Clinic to Earn AAAASF Accreditation for Patient Safety 2018-06-07 23:00
Oncologie Launches with 16.5M USD Seed Funding Led by Pivotal bioVenture Partners China 2018-06-07 20:00
Luye expanding I-O deal with U.S. firm Elpis to focus on CAR T therapies 2018-06-07 18:03
Seroquel Stepping Stone: How Luye Will Use Seroquel to Expand in Emerging Markets 2018-06-07 07:45
Hangzhou Just Biotherapeutics Secures $35 Million Series B+ Financing 2018-06-06 21:00
Frost & Sullivan Publishes Q1-2018 and 12 months since Initiation Updates Coverage Report on RedHill BioPharma Ltd. 2018-06-06 18:00
Mundipharma Gains License to Market and Distribute GUARDIX-SG (TM) in Southeast Asia 2018-06-06 10:58
Merck Brings Biotechs Closer to Drug Therapy Production and Commercialization 2018-06-05 20:00
Sanofi CEO Olivier Brandicourt: Continue to Increase Investment in China to Help Establish an Innovated-in-China Benchmark in Healthcare 2018-06-04 12:07
Takeda Highlights Favorable Safety Profile of Entyvio(R) (vedolizumab) Through Comparative Real-World Data Versus TNFα-Antagonist Therapy in Ulcerative Colitis and Crohn's Disease 2018-06-04 12:04
Menarini Ricerche to Present the Study Design of CD205-Shuttle, a First-in-human Trial of MEN1309/OBT076, at the ASCO Annual Meeting 2018 2018-06-01 21:18
ASSOCHAM Pharma Excellence Awards 2018 Privileged Veeda Clinical Research With 'Best Clinical Research 2018' Award 2018-05-30 09:00
Chipscreen Biosciences Announces that a Pivotal Phase III Clinical Trial of Chidamide in Combination with Exemestane in Patients with Breast Cancer Reached Primary Endpoint 2018-05-29 18:00
OliX Pharmaceuticals receives Clinical Trial Authorization in the UK to initiate Phase I study with OLX10010, an anti-scar RNAi therapeutics 2018-05-29 16:01
1 356 357 358 359 360 412